Announcement
09 Jun 2020
In June 2020, the Norwegian authorities introduced an export ban on certain immunoglobulins following the outbreak of COVID-19.
Source
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
Implementation date
09 Jun 2020
Revocation date:
14 Jun 2020
On 9 June 2020, the Norwegian Medicines Agency introduced an export ban on immunoglobulins specifically hizentra 200 mg/ml, 20ml hgl. The export ban was introduced as it is considered a COVID-19 re...
See all
This state act is not part of any Thread yet.